CVN-424: Cerevance's Lead Therapeutic - A First-in-Class, Oral, Non-Dopaminergic Compound acting on a Novel Target (GPR6) - Market Size, Forecast, and Emerging Insights for 7MM 2019-2032
April 05, 2024 08:59 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "CVN-424 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
INBRIJA: A Dry Powder Formulation of Levodopa for Oral Inhalation with Inhaler - Market Size, Forecast, and Market Insights for 7MM 2019-2032
April 05, 2024 08:57 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "INBRIJA Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
NOURIANZ Market Size, Forecast, and Market Insight - 2032
April 05, 2024 08:55 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "NOURIANZ Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
KYNMOBI Drug Landscape Research 2024: A Sublingual Film Containing Apomorphine Hydrochloride - Market Size, Forecast, and Market Insight for 7MM 2019-2032
April 05, 2024 08:54 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "KYNMOBI Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
ABBV-951 for Parkinson's Disease: An Investigational Drug-Containing Foslevodopa/Foscarbidopa Being Developed by AbbVie - Market Size, Forecast, and Market Insights to 2032
April 05, 2024 08:52 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "ABBV-951 Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This "report provides...
BIIB-122 for Parkinson's Disease in 7MM: Market Size, Forecast, and Emerging Insight 2019-2032 - Focus on United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan
April 05, 2024 08:50 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "BIIB-122 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
XADAGO for Parkinson's Disease in 7MM: Clinical Assessment, Market Size, Forecasts, and Insights 2019-2032 - Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
April 05, 2024 04:41 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "XADAGO Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
NE-3107 for Parkinson's Disease in 7MM: Clinical Status, Market Size, Forecasts, and Emerging Insights 2019-2032 - Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
April 05, 2024 04:37 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "NE-3107 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Tavapadon for Parkinson's Disease for 7MM: Market Size, Forecast, and Emerging Insights 2019-2032 - Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
April 05, 2024 04:36 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Tavapadon Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...